Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial.
Maria Johanna Gobertina Tetuanui VehreschildPetar A AtanasovKateryna YurkoCristian OanceaGeorgi PopovValentina SmesnoiGheorghe PlacintaHella KohlhofDaniel VittEvelyn PeelenJelena MihajlovićAndreas R MuehlerPublished in: Infectious diseases and therapy (2022)
These findings support vidofludimus calcium being safe and well tolerated in patients with COVID-19.